Zentalis Pharmaceuticals
ZNTL
ZNTL
120 hedge funds and large institutions have $1.27B invested in Zentalis Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $1.61B → $1.27B (-$345M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
120
Holding in Top 10
2
Calls
$3.79M
Puts
–
Top Buyers
| 1 | +$37.6M | |
| 2 | +$18.6M | |
| 3 | +$13.8M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$5.52M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$4.54M |
Top Sellers
| 1 | -$56.9M | |
| 2 | -$45.1M | |
| 3 | -$10.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.36M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.84M |